Who Thermo Fisher buys from and sells to
Sells lab instruments, consumables, CRO trials (PPD) and contract drug manufacturing to pharma, biotech and academia.
Part of GLP-1 and Specialty Pharmaceuticals spending
Sells to 3
- SanofiSNYfill-finish at the Ridgefield, NJ site bought from Sanofi in 2025
- US National Institutes of Healthgrant money that funds academic lab purchases
- Pharma and biotech trial sponsorsPPD clinical research and Patheon contract manufacturing
Where the chain could break
- Academic and government demand rides on NIH and other public research budgets
- Pharma services volume tracks biotech funding and drug-trial starts
- Pending ~$9bn Clario purchase, expected to close by end-2026, adds debt
Competes with
- DanaherDHRbioprocess consumables and life-science instruments
- AgilentAanalytical instruments and lab consumables
- IQVIAIQVoutsourced clinical trials against PPD
- AvantorAVTRlab-supply distribution against Fisher Scientific
Mapped by hand from filings and company reporting, as of October 2026. It shows the relationships that matter most, not every contract: most are never disclosed, and agreements change.